These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9231923

  • 1. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
    Vaidyanathan G, Zhao XG, Larsen RH, Zalutsky MR.
    Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
    [Abstract] [Full Text] [Related]

  • 2. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Vaidyanathan G, Zhao XG, Strickland DK, Zalutsky MR.
    J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model.
    Vaidyanathan G, Friedman HS, Keir ST, Zalutsky MR.
    Nucl Med Biol; 1996 Aug; 23(6):851-6. PubMed ID: 8940730
    [Abstract] [Full Text] [Related]

  • 4. Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent.
    Vaidyanathan G, Strickland DK, Zalutsky MR.
    Int J Cancer; 1994 Jun 15; 57(6):908-13. PubMed ID: 8206683
    [Abstract] [Full Text] [Related]

  • 5. 1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation.
    Vaidyanathan G, Zalutsky MR.
    Bioconjug Chem; 1992 Jun 15; 3(6):499-503. PubMed ID: 1463779
    [Abstract] [Full Text] [Related]

  • 6. Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
    Strickland DK, Vaidyanathan G, Friedman HS, Zalutsky MR.
    J Neurooncol; 1995 Jun 15; 25(1):9-17. PubMed ID: 8523094
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
    Strickland DK, Vaidyanathan G, Zalutsky MR.
    Cancer Res; 1994 Oct 15; 54(20):5414-9. PubMed ID: 7923174
    [Abstract] [Full Text] [Related]

  • 8. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
    Vaidyanathan G, Affleck DJ, Zalutsky MR.
    J Nucl Med; 1995 Apr 15; 36(4):644-50. PubMed ID: 7699460
    [Abstract] [Full Text] [Related]

  • 9. Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.
    Batra V, Samanta M, Makvandi M, Groff D, Martorano P, Elias J, Ranieri P, Tsang M, Hou C, Li Y, Pawel B, Martinez D, Vaidyanathan G, Carlin S, Pryma DA, Maris JM.
    Clin Cancer Res; 2022 Sep 15; 28(18):4146-4157. PubMed ID: 35861867
    [Abstract] [Full Text] [Related]

  • 10. (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography.
    Vaidyanathan G, Affleck DJ, Zalutsky MR.
    J Med Chem; 1994 Oct 14; 37(21):3655-62. PubMed ID: 7932592
    [Abstract] [Full Text] [Related]

  • 11. No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine.
    Vaidyanathan G, Affleck DJ, Zalutsky MR.
    Bioconjug Chem; 1996 Oct 14; 7(1):102-7. PubMed ID: 8741997
    [Abstract] [Full Text] [Related]

  • 12. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
    Vaidyanathan G, Welsh PC, Vitorello KC, Snyder S, Friedman HS, Zalutsky MR.
    Eur J Nucl Med Mol Imaging; 2004 Oct 14; 31(10):1362-70. PubMed ID: 15205923
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
    Vaidyanathan G, McDougald D, Koumarianou E, Choi J, Hens M, Zalutsky MR.
    Nucl Med Biol; 2015 Aug 14; 42(8):673-84. PubMed ID: 25956997
    [Abstract] [Full Text] [Related]

  • 14. Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma.
    Mairs RJ, Russell J, Cunningham S, O'Donoghue JA, Gaze MN, Owens J, Vaidyanathan G, Zalutsky MR.
    Eur J Cancer; 1995 Aug 14; 31A(4):576-81. PubMed ID: 7576972
    [Abstract] [Full Text] [Related]

  • 15. Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
    Cunningham SH, Mairs RJ, Wheldon TE, Welsh PC, Vaidyanathan G, Zalutsky MR.
    Br J Cancer; 1998 Jun 14; 77(12):2061-8. PubMed ID: 9649115
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R, Pecorale A, Chinol M, Calcagni ML, Servidei T, Riccardi R, Troncone L.
    Q J Nucl Med; 1995 Dec 14; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
    Gaze MN, Hamilton TG, Mairs RJ.
    Br J Radiol; 1994 Jun 14; 67(798):573-8. PubMed ID: 8032811
    [Abstract] [Full Text] [Related]

  • 18. Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells.
    Vaidyanathan G, Affleck DJ, Alston KL, Welsh P, Zalutsky MR.
    Nucl Med Commun; 2004 Sep 14; 25(9):947-55. PubMed ID: 15319601
    [Abstract] [Full Text] [Related]

  • 19. Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
    Fullerton NE, Boyd M, Ross SC, Pimlott SL, Babich J, Kirk D, Zalutsky MR, Mairs RJ.
    Med Chem; 2005 Nov 14; 1(6):611-8. PubMed ID: 16787344
    [Abstract] [Full Text] [Related]

  • 20. Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
    Armour A, Mairs RJ, Gaze MN, Wheldon TE.
    Br J Cancer; 1994 Sep 14; 70(3):445-8. PubMed ID: 8080728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.